Imvaria
IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. IMVARIA serves Fibresolve - the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA Breakthrough Device and is authorized by the FDA to serve as an adjunctive, non-invasive diagnostic tool for patients with suspected ILD and IPF. Beyond ILD and IPF, IMVARIA is developing AI biomarkers in multiple areas including oncology, pulmonology, immunology, and more.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
7
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
1
organic / mo
Sign up free to see all 6 verified contacts at Imvaria
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- TD
Tj Dunham
Sales Specialist · Sales & Business Development
EmailPhone - DB
Don Bigler
Vice President of Engineering · Other
EmailPhone - JR
Joshua Reicher
Co-founder · Other
EmailPhone - MC
Michael C. Muelly
Chief Technology Officer, Co-founder · Other
EmailPhone
Showing 4 of 6 verified contacts
Top roles at Imvaria
5 distinct titles indexed · top 5 shown.
- 1chief technology officer, co-founder
- 1co-founder
- 1sales specialist
- 1software developer engineer in test
- 1vice president of engineering
Sign up to unlock all 6 contacts at Imvaria
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Imvaria
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.